Cullen is one of the very few companies still sending a hard copy annual report,which I read cover to cover .my assessment is that no money is to be made here while the company has a business model of prospect generation and farm out, run by 20 year company veterans who should be retired with their shares ...now this may be a bit mean spirited but the fact remains we need a transfusion of new blood....we can no longer look at projects through tired eyes..
- Forums
- ASX - By Stock
- Ann: Update - Consolidation/Split - CUL
Cullen is one of the very few companies still sending a hard...
Add CUL (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.5¢ |
Change
-0.001(16.7%) |
Mkt cap ! $4.160M |
Open | High | Low | Value | Volume |
0.5¢ | 0.5¢ | 0.5¢ | $491 | 98.25K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 2336285 | 0.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.6¢ | 2947153 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 183530 | 0.012 |
1 | 90820 | 0.011 |
1 | 99900 | 0.010 |
2 | 178000 | 0.009 |
1 | 1428714 | 0.007 |
Price($) | Vol. | No. |
---|---|---|
0.014 | 45602 | 1 |
0.015 | 75598 | 1 |
0.016 | 80000 | 1 |
0.017 | 711750 | 1 |
0.018 | 267069 | 1 |
Last trade - 13.19pm 27/09/2024 (20 minute delay) ? |
CUL (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, Managing Director and CEO
Steven Gourlay
Managing Director and CEO
Previous Video
Next Video
SPONSORED BY The Market Online